Inaktiver Wert

Albany Molecular Research, Inc. Aktie Deutsche Boerse AG

Aktien

Dauer

Zeitraum

Stil

Albany Molecular Research : AMRI Experts to Lead Discussion on Bringing a Medical Device to Market at MD&M Wes...	17.01.18
Albany Molecular Research : AMRI Names Michael Mulhern as Chief Executive Officer	04.01.18
Albany Molecular Research : AMRI’s SSCI Implements Next-Generation Analytical Instrumentation to Further Strengthen...	19.12.17
Albany Molecular Research : AMRI Doubles Bulk API Aseptic Manufacturing Capacity	30.11.17
Albany Molecular Research : AMRI Presents Expanded Capabilities at 2017 AAPS Annual Meeting	09.11.17

Manager	Titel	Alter	Seit
Philip W Macnabb CEO	Chief Executive Officer	-	01.05.23
Meera Khullar CMP	Compliance Officer	-	01.03.19
Prakash Pandian CTO	Chief Tech/Sci/R&D Officer	-	01.06.18

Aufsichtsräte	Titel	Alter	Seit
Dean Mihas BRD	Director/Board Member	57	-
Sean Cunningham BRD	Director/Board Member	48	-
William McMullan BRD	Director/Board Member	46	-

Sektor

	% 1. Jan.	Kap.
IQVIA HOLDINGS INC.	-0,09 %	42,12 Mrd.
LONZA GROUP AG	+49,62 %	42,05 Mrd.
CELLTRION, INC.	-4,96 %	29,18 Mrd.
ICON PUBLIC LIMITED COMPANY	+11,18 %	26,02 Mrd.
ALNYLAM PHARMACEUTICALS, INC.	-21,95 %	18,9 Mrd.
BIO-TECHNE CORPORATION	+8,61 %	13,21 Mrd.
UNITED THERAPEUTICS CORPORATION	+24,73 %	12,17 Mrd.
MEDPACE HOLDINGS, INC.	+28,31 %	12,16 Mrd.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-6,26 %	11,42 Mrd.